Latest Announcements

Sanofi India Limited has informed the Exchange about Re-constitution of the Committees of the Company. The Board of Directors at its meeting held today, considered and approved the Unaudited Financial Results for the quarter and half year ended 30th June 2026. The company reported domestic net sales growth of 8% and total net sales growth of 6% compared to the second quarter of 2025. The Insulin portfolio delivered double-digit growth of 14% for the second consecutive quarter.

Aequs Ltd's Q1 FY27 earnings conference call transcript reveals a strong start to the year, with consolidated revenue growing 55% YoY to INR3,955 million. The company's consumer segment nearly tripled, and its aerospace segment grew 40% YoY. However, reported EBITDA was lower than Q4 due to other income and foreign exchange. Excluding these factors, EBITDA improved sequentially, driven by narrowing consumer loss.

Sanofi India Ltd has announced its Q2 2026 financial results, reporting 8% domestic net sales growth and 6% total net sales growth compared to Q2 2025. The company's insulin portfolio delivered double-digit growth of 14% for the second consecutive quarter, driven by strong performance of Lantus, Toujeo, and Apidra. Profits before tax and exceptional items increased 19% to INR 112 crores, with profit before tax as a percentage of net sales improving to 27% in Q2 2026.

Sanofi India Limited has announced its Q2 2026 financial results, reporting 8% domestic net sales growth and 6% total net sales growth compared to Q2 2025. The company's insulin portfolio delivered double-digit growth of 14%, driven by strong performance of Lantus, Toujeo, and Apidra. Profits before tax and exceptional items increased 19% to INR 112 crores, with profit before tax as a percentage of net sales improving to 27%.

Sanofi India Ltd has announced its Q2 2026 financial results, with domestic net sales growth of 8% and total net sales growth of 6% compared to the second quarter of 2025. The company's insulin portfolio delivered double-digit growth of 14% for the second consecutive quarter, driven by strong performance of Lantus, Toujeo, and Apidra. Profits before tax and exceptional items increased 19% to INR 112 crores, with profit before tax as a percentage of net sales improving to 27% in Q2 2026.

Sanofi India Limited has announced its financial results for the quarter ended June 30, 2026, with domestic net sales growth of 8% and total net sales growth of 6% compared to the second quarter of 2025. The company's insulin portfolio delivered double-digit growth of 14% for the second consecutive quarter, and profits before tax and exceptional items increased 19% to INR 112 crores.

Aequs Limited has informed the Exchange about Transcript of Earnings Conference Call held on July 29, 2026, pertaining to the Un-audited Financial Results of the Company for the quarter ended June 30, 2026. The company reported a 55% year-on-year growth in consolidated revenue to INR3,955 million, with aerospace growing 40% year-on-year and consumer segment nearly tripling. The company's operational EBITDA improved from INR42 million in Q4 to INR148 million, driven by narrowing consumer loss.

Birlasoft Ltd reported Q1 FY27 earnings with revenue growth of 0.3% in constant currency quarter-on-quarter, but 2.3% in rupee terms, and 7.4% year-on-year. EBITDA margins normalized to 16.1% without one-off items, and cash collections were strong, leading to increased cash balances. The company also signed $168.7 million of TCV signings, up 20% year-on-year, including several AI-led engagements.

Birlasoft Limited has announced its Q1 FY27 earnings, with revenue growth of 0.3% in constant currency quarter-on-quarter and 2.3% in rupee terms. EBITDA margins have normalized to 16.1%, and cash collections have been strong, resulting in increased cash balances. The company has also seen strong deal signings, including a $168.7 million TCV signing, and has renewed and expanded its strategic engagement with a leading financial services player in the U.S.

Refex Industries Limited held an earnings conference call to discuss their Q1 FY27 financial results, highlighting a strong operational performance in their ash and coal handling business, driven by robust execution, a healthy order pipeline, and continued progress across strategic growth platforms.

Refex Industries Limited has announced its Q1 FY27 earnings conference call transcript, highlighting a strong operational performance in its ash and coal handling business, driven by robust execution, a healthy order pipeline, and continued progress across strategic growth platforms. The company's integrated approach has enabled a robust nationwide ecosystem for sustainable ash management, making it the most preferred vendor for thermal power plants.

PTC India Ltd announced its consolidated & standalone financial results for Q1-FY27, with a 12% growth in trading volume, and a consolidated PAT of INR 112.08 Crores. The company also declared an interim dividend of Rs 23/- per share.

Sanofi India Ltd announced its financial results for Q2 2026, reporting domestic net sales growth of 8% and total net sales growth of 6% compared to Q2 2025. The Insulin portfolio delivered double-digit growth of 14% for the second consecutive quarter, driven by Lantus, Toujeo, and Apidra. Profit before tax and exceptional items increased 19% to INR 112 crores, with profit before tax as a percentage of net sales improving to 27% in Q2 2026.

ONGC declares Q1 FY'27 results with a net profit of ₹ 17,034 crore, a 112% increase from the same period last year, driven by a 45% rise in gross revenue to ₹ 46,460 crore.

Sanofi India Ltd has announced its Q2 2026 financial results, reporting 8% domestic net sales growth and 6% total net sales growth compared to Q2 2025. The company's insulin portfolio delivered double-digit growth of 14% for the second consecutive quarter, driven by strong performance of Lantus, Toujeo, and Apidra. Profits before tax and exceptional items increased 19% to INR 112 crores, with profit before tax as a percentage of net sales improving to 27%.

ONGC declares Q1 FY 27 results with a 112% increase in net profit to ₹ 17,034 crore, driven by a 45% increase in gross revenue to ₹ 46,460 crore.

Sanofi India Ltd reported its unaudited financial results for the quarter and half year ended 30th June 2026, with domestic net sales growth of 8% and total net sales growth of 6% compared to the second quarter of 2025. The company's profits before tax and exceptional items increased 19% to INR 112 crores, with a profit before tax as a percentage of net sales improving to 27% in Q2 2026.

Rashi Peripherals Ltd has released an investor presentation on its unaudited financial results for the quarter ended June 30, 2026, highlighting its growth, strengths, and value proposition in the ICT distribution business.

PTC India Limited has announced its consolidated and standalone financial results for the first quarter FY 2026-27, with a 12% growth in trading volume and a consolidated profit before tax of INR 150.96 Crores. The company has declared an interim dividend of Rs 23 per share of face value Rs 10. The management commentary suggests that the company's business model has shown resilience in a scenario where the market is in transition.

Caliber Mining and Logistics Limited has informed the Exchange about Credit Rating- Revision, with CRISIL Ratings Limited upgrading the company's credit rating to Crisil A-/Positive from Crisil BBB+/Stable for long-term bank facilities and Crisil A2+ from Crisil A2 for short-term bank facilities.